Literature DB >> 33384046

Costs along the TB diagnostic pathway in Uganda.

A Tucker1, D Oyuku2, T Nalugwa2, M Nantale2, O Ferguson1, K Farr3, T F Reza4, P B Shete5, A Cattamanchi5, D W Dowdy6, H Sohn1, A Katamba7.   

Abstract

Entities:  

Year:  2021        PMID： 33384046      PMCID： PMC7927348          DOI： 10.5588/ijtld.20.0532

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  14 in total

1.  Allowing for differential timing in cost analyses: discounting and annualization.

Authors:  Damian Walker; Lilani Kumaranayake
Journal:  Health Policy Plan       Date:  2002-03       Impact factor: 3.344

2.  Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation.

Authors:  Anil Pooran; Grant Theron; Lynn Zijenah; Duncan Chanda; Petra Clowes; Lawrence Mwenge; Farirai Mutenherwa; Paul Lecesse; John Metcalfe; Hojoon Sohn; Michael Hoelscher; Alex Pym; Jonny Peter; David Dowdy; Keertan Dheda
Journal:  Lancet Glob Health       Date:  2019-06       Impact factor: 26.763

3.  Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert® MTB/RIF for People Living with HIV/AIDS and People with Presumptive Multidrug-resistant Tuberculosis.

Authors:  Sarah Wood Pallas; Marissa Courey; Chhaily Hy; Wm Perry Killam; Dora Warren; Brittany Moore
Journal:  Appl Health Econ Health Policy       Date:  2018-08       Impact factor: 2.561

4.  Higher cost of implementing Xpert(®) MTB/RIF in Ugandan peripheral settings: implications for cost-effectiveness.

Authors:  E Hsiang; K M Little; P Haguma; C F Hanrahan; A Katamba; A Cattamanchi; J L Davis; A Vassall; D Dowdy
Journal:  Int J Tuberc Lung Dis       Date:  2016-09       Impact factor: 2.373

5.  Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform.

Authors:  Nora Engel; Keri Wachter; Madhukar Pai; Jim Gallarda; Catharina Boehme; Isabelle Celentano; Rebecca Weintraub
Journal:  BMJ Glob Health       Date:  2016-12-02

6.  How to implement new diagnostic products in low-resource settings: an end-to-end framework.

Authors:  Melissa Latigo Mugambi; Trevor Peter; Samuel F Martins; Cristina Giachetti
Journal:  BMJ Glob Health       Date:  2018-11-16

7.  Estimators Used in Multisite Healthcare Costing Studies in Low- and Middle-Income Countries: A Systematic Review and Simulation Study.

Authors:  Emma Clarke-Deelder; Anna Vassall; Nicolas A Menzies
Journal:  Value Health       Date:  2019-07-30       Impact factor: 5.725

8.  Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.

Authors:  Neeraj Raizada; K S Sachdeva; Achuthan Sreenivas; Bhavin Vadera; R S Gupta; Malik Parmar; Shubhangi Kulsange; Ameet Babre; Rahul Thakur; Christen Gray; Ranjani Ramachandran; Umesh Alavadi; Mayank Ghedia; Balasangameshwara Vollepore; Puneet Dewan; Catharina Boehme; C N Paramsivan
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

9.  Uganda's new national laboratory sample transport system: a successful model for improving access to diagnostic services for Early Infant HIV Diagnosis and other programs.

Authors:  Charles Kiyaga; Hakim Sendagire; Eleanor Joseph; Ian McConnell; Jeff Grosz; Vijay Narayan; Godfrey Esiru; Peter Elyanu; Zainab Akol; Wilford Kirungi; Joshua Musinguzi; Alex Opio
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model.

Authors:  Hojoon Sohn; Parastu Kasaie; Emily Kendall; Gabriela B Gomez; Anna Vassall; Madhukar Pai; David Dowdy
Journal:  BMC Med       Date:  2019-08-06       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.